EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Compelling Evidence: A Critical Update on the Therapeutic Potential of Carbon Monoxide

Nicola Bauer, Qiyue Mao, Aditi Vashistha iD, Anupamaa Seshadri, Yi-Chieh Nancy Du iD, Leo Otterbein, Chalet Tan iD, Mark P de Caestecker, Binghe Wang iD

Medicinal Research Reviews · 2025-07 · 45 (4) · 1275-1301

DOI: 10.1002/med.22116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 30.04.2025. Verfasst von Nicola Bauer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Carbon Monoxide. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 235 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, This research was supported by the National Institutes of Health (R01DK119202 in support of CO and colitis and R01DK128823 in support of CO and kidney injury)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbon monoxide (CO) is an endogenous signaling molecule. It is produced via heme degradation by heme oxygenase (HMOX), releasing stoichiometric amounts of CO, iron, and biliverdin (then bilirubin). The HMOX‐CO axis has long been shown to offer beneficial effects by modulating inflammation, proliferation and cell death as they relate to tissue and organ protection. Recent years have seen a large number of studies examining CO pharmacology, its molecular targets, cellular mechanisms of action, pharmacokinetics, and detection methods using various delivery modalities including inhaled CO gas, CO solutions, and various types of CO donors. Unfortunately, one widely used donor type includes four commercially available carbonyl complexes with metal or borane, CORM‐2 (Ru 2+ ), CORM‐3 (Ru 2+ ), CORM‐A1 (BH 3 ), and CORM‐401 (Mn + ), which have been shown to have minimal and/or unpredictable CO production and extensive CO‐independent chemical reactivity and biological activity. As a result, not all “CO biological activities” in the literature can be attributed to CO. In this review, we summarize key findings based on CO gas and CO in solution for the certainty of the active principal and to avoid data contamination resulting from the confirmed or potential reactivities and activities of the “carrier” portion of CORMs. Along a similar line, we discuss interesting potential research areas of CO in the brain including a newly proposed CO/HMOX/dopamine axis and the role of CO in cognitive stimulation and circadian rhythm. This review is critical for the future development of the CO field by steering clear of complications caused by chemically reactive donor molecules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon MonoxideHumansAnimals

Stichwörter der Autor:innen

anti‐inflammationcarbon monoxide (CO)carbon monoxide‐releasing molecule (CORM)cytoprotectionorgan protection

Substanzen

Carbon Monoxide

Autor:innen und Institutionen

  • Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia, USA.
  • Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York City, New York, USA.
  • Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Aditi Vashistha, Yi-Chieh Nancy Du, Chalet Tan, Binghe Wang

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • This research was supported by the National Institutes of Health (R01DK119202 in support of CO and colitis and R01DK128823 in support of CO and kidney injury).

Zitieren

APA

Bauer, N., Mao, Q., Vashistha, A., Seshadri, A., Nancy Du, Y. C., Otterbein, L., Tan, C., de Caestecker, M. P., & Wang, B. (2025). Compelling Evidence: A Critical Update on the Therapeutic Potential of Carbon Monoxide. Medicinal Research Reviews, 45(4), 1275-1301. https://doi.org/10.1002/med.22116

Vancouver

Bauer N, Mao Q, Vashistha A, Seshadri A, Nancy Du YC, Otterbein L, et al. Compelling Evidence: A Critical Update on the Therapeutic Potential of Carbon Monoxide. Medicinal Research Reviews. 2025;45(4):1275-1301. doi:10.1002/med.22116

BibTeX
@article{Bauer2025,
  author = {Bauer, Nicola and Mao, Qiyue and Vashistha, Aditi and Seshadri, Anupamaa and Nancy Du, Yi-Chieh and Otterbein, Leo and Tan, Chalet and de Caestecker, Mark P and Wang, Binghe},
  title = {Compelling Evidence: A Critical Update on the Therapeutic Potential of Carbon Monoxide},
  journal = {Medicinal Research Reviews},
  year = {2025},
  volume = {45},
  number = {4},
  pages = {1275--1301},
  doi = {10.1002/med.22116}
}
Kostenlos starten →